| 발표일자: |
2014년 4월 12일(토) ~ 4월 13일(일) |
| 발표번호: |
P(e-poster)-035 |
| 발표장소: |
킨텍스 제2전시장 7B홀 |
|
|
| Factors Influencing the Exudation Recurrence after Cataract Surgery in Patients Previously Treated with Anti-Vascular Endothelial Growth Factor for Exudative Age-Related Macular Degeneration |
| 건양의대 김안과병원 안과학교실, 명곡안연구소 |
| 최성찬, 이태곤, 장영석, 김철구, 김종우, 김재휘 |
|
목적 : To investigate factors influencing exudation recurrence following cataract surgery in patients already treated with anti-vascular endothelial growth factor (VEGF) agents for exudative age-related macular degeneration (AMD)
방법 : A retrospective review of medical records was performed for patients who underwent cataract surgery and had been previously treated with anti-VEGF for exudative AMD. Visual acuity was examined before surgery and 1 and 6 months after surgery. The time between diagnosis and surgery, and the exudation-free period before surgery were examined and compared between patients who had exudation recurrence and those that did not.
결과 : Thirty-nine eyes of 39 patients were included in analyses. The logarithm of the minimum angle of resolution visual acuity was 1.03 ± 0.59 and had significantly improved 1 (0.82 ± 0.63, P < 0.001) and 6 months (0.85 ± 0.64, P = 0.001) following surgery. Both the diagnosis-to-surgery period (P = 0.001) and the preoperative exudation-free period (P < 0.001) were significantly longer in patients without recurrence than in patients with recurrence.
결론 : Cataract surgery was beneficial in patients previously treated with anti-VEGF for exudative AMD. To minimize exudation recurrence, cataract surgery should be planned after a sufficiently long exudation-free period.
|
| |